Jonathan Hahn - Kamada Director

KMDA Stock  ILA 2,140  26.00  1.20%   

Director

Mr. Jonathan Hahn is Director of the company. He has served on our board of directors since March 2010. Mr. Hahn is currently the President and a director of Tuteur. Previously, Mr. Hahn held a business development position in Forest Laboratories, Inc., based in New York since 2010.
Age 32
Tenure 14 years
Professional MarksMBA
Phone(972) 8 9406472
Webwww.kamada.com
Hahn holds a BA degree from San Andrés University and an MBA degree from New York University — Stern School of Business, with specializations in Finance and Entrepreneurship.

Kamada Management Efficiency

Kamada's management efficiency ratios could be used to measure how well Kamada manages its routine affairs as well as how well it operates its assets and liabilities.
Kamada has accumulated 17.41 M in total debt with debt to equity ratio (D/E) of 0.03, which may suggest the company is not taking enough advantage from borrowing. Kamada has a current ratio of 6.72, suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due. Debt can assist Kamada until it has trouble settling it off, either with new capital or with free cash flow. So, Kamada's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Kamada sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Kamada to invest in growth at high rates of return. When we think about Kamada's use of debt, we should always consider it together with cash and equity.

Similar Executives

Found 8 records

DIRECTOR Age

Ovadia EliICL Israel Chemicals
74
Sagi KablaICL Israel Chemicals
43
Reem AminoachICL Israel Chemicals
58
Aviad KaufmanICL Israel Chemicals
49
Lior ReitblattICL Israel Chemicals
62
Avisar PazICL Israel Chemicals
63
Nadav KaplanICL Israel Chemicals
74
Ruth RalbagICL Israel Chemicals
59
Kamada Ltd. develops, produces, and markets plasma-derived protein therapeutics for orphan indications. The company was incorporated in 1990 and is headquartered in Rehovot, Israel. KAMADA operates under Drug ManufacturersSpecialty Generic classification in Israel and is traded on Tel Aviv Stock Exchange. It employs 408 people. Kamada (KMDA) is traded on Tel Aviv Stock Exchange in Israel and employs 355 people.

Management Performance

Kamada Leadership Team

Elected by the shareholders, the Kamada's board of directors comprises two types of representatives: Kamada inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Kamada. The board's role is to monitor Kamada's management team and ensure that shareholders' interests are well served. Kamada's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Kamada's outside directors are responsible for providing unbiased perspectives on the board's policies.
Pnina Strauss, Vice President - Inhalation programs & IP
Itzhak Krinsky, Director
Lilach Topilsky, Chairman of the Board
Ari Shamiss, Director
Barak Bashari, Vice President - Operations
Eran Schenker, Vice President - Medical Director
Tuvia Shoham, Independent Director
Eran Nir, Chief Officer
Hanni Neheman, VP Sales
Michal Stein, Vice President and Medical Director for Immunology
Ariella Raban, VP HR
Shani Dotan, Vice President of Human Resources
Yael Brenner, Vice President - Quality
Abraham Havron, Independent Director
Ruth Wolfson, Senior Vice President - Scientific Affairs
Shmuel Rubinstein, Director
Naveh Tov, Vice President-Clinical Development and Medical Director for Pulmonary Diseases
Jon Knight, VP Operations
Michael Berelowitz, Director
David Tsur, Co-Founder and Deputy Executive Chairman
Orit Pinchuk, Vice President - Regulatory Affairs and Quality R&D
Leon Recanati, Chairman of the Board
Jonathan Hahn, Director
Gwen Melincoff, Director
Chaime Orlev, Chief Financial Officer
Michal Ayalon, Vice President - Research & Development
Yifat Esq, Gen Legal
Amir London, Chief Executive Officer
Estery GilozRan, Independent Director
Eitan Kyiet, Vice President - Business Development

Kamada Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Kamada a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Information and Resources on Investing in Kamada Stock

When determining whether Kamada offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Kamada's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Kamada Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Kamada Stock:
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Kamada. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
For information on how to trade Kamada Stock refer to our How to Trade Kamada Stock guide.
You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Please note, there is a significant difference between Kamada's value and its price as these two are different measures arrived at by different means. Investors typically determine if Kamada is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Kamada's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.